BHC.TO Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:00):

Stats
Tagesvolumen	407 474
Durchschnittsvolumen	371 546
Marktkapitalisierung	4.43B
EPS	$0 ( 2024-02-21 )
Nächstes Ertragsdatum	( $0.940 ) 2024-05-01
Last Dividend	$0.0970 ( 2010-08-30 )
Next Dividend	$0 ( N/A )
P/E	-5.46
ATR14	$0.00700 (0.06%)

Volumen Korrelation

Lang: 0.36 (neutral)

Kurz: 0.87 (strong)

Signal:(80.233) Same movement expected

BAUSCH HEALTH COMPANIES Korrelation

10 Am meisten positiv korreliert
HOM-UN.TO	0.907
CJR-B.TO	0.898
MTY.TO	0.893
GOOS.TO	0.885
ERO.TO	0.882
LUN.TO	0.88
LB.TO	0.877
CARS.TO	0.875
IGM.TO	0.872
D-UN.TO	0.871

10 Am meisten negativ korreliert
QBTL.TO	-0.877
UNS.TO	-0.87
SBB.TO	-0.855
E.TO	-0.844
ABCT.TO	-0.836
SFC.TO	-0.822
THNC.TO	-0.822

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

BAUSCH HEALTH COMPANIES Korrelation - Währung/Rohstoff

0.32
( neutral )

0.37
( neutral )

0.00
( neutral )

0.24
( neutral )

-0.12
( neutral )

-0.77
( moderate negative )

BAUSCH HEALTH COMPANIES Finanzdaten

Annual	2023
Umsatz:	$8.76B
Bruttogewinn:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2023
Umsatz:	$8.76B
Bruttogewinn:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2022
Umsatz:	$8.12B
Bruttogewinn:	$5.76B (70.90 %)
EPS:	$-0.590

FY	2021
Umsatz:	$8.43B
Bruttogewinn:	$6.04B (71.61 %)
EPS:	$-2.64

Financial Reports:

No articles found.

BAUSCH HEALTH COMPANIES Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

BAUSCH HEALTH COMPANIES Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.74 - low (57.34%) | Divividend Growth Potential Score: 3.23 - No dividend growth expected in the near future

Information

First Dividend	$0.598	2005-11-28
Last Dividend	$0.0970	2010-08-30
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	20	--
Total Paid Out	$5.49	--
Avg. Dividend % Per Year	0.00%	--
Score	2.9	--
Div. Sustainability Score	4.74
Div.Growth Potential Score	3.23
Div. Directional Score	3.98	--

Next Divdend (Est)
(2024-08-05)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.90

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
ZESG.TO	Dividend Junior	2023-06-28	Quarterly	5	1.17%
STLC.TO	Dividend King	2023-08-17	Quarterly	7	3.37%
HUBL.TO	Dividend Knight	2023-08-30	Monthly	7	3.76%
CBH.TO	Dividend King	2023-09-25	Monthly	13	1.79%
XDUH.TO	Dividend Knight	2023-08-25	Monthly	7	1.47%
PLC.TO	Dividend Knight	2023-06-29	Bi-Monthly	14	0.77%
EXE.TO	Dividend King	2023-09-28	Monthly	13	4.13%
ZRE.TO	Dividend Knight	2023-08-29	Monthly	15	2.60%
TLF.TO	Dividend King	2023-08-30	Monthly	13	3.15%
L-PB.TO	Dividend King	2023-09-14	Quarterly	10	3.24%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0685	1.500	-1.370	-2.06	[0 - 0.5]
returnOnAssetsTTM	-0.0219	1.200	-0.731	-0.878	[0 - 0.3]
returnOnEquityTTM	0.618	1.500	4.24	6.36	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.301	0.800	8.50	6.80	[1 - 3]
quickRatioTTM	0.685	0.800	-0.679	-0.543	[0.8 - 2.5]
cashRatioTTM	0.220	1.500	9.89	10.00	[0.2 - 2]
debtRatioTTM	0.819	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0.725	1.000	-0.843	-0.843	[3 - 30]
operatingCashFlowPerShareTTM	3.09	2.00	8.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.30	2.00	8.85	10.00	[0 - 20]
debtEquityRatioTTM	-21.91	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.708	1.000	1.537	1.537	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0489	1.000	-0.839	-0.839	[0.2 - 2]
assetTurnoverTTM	0.320	0.800	-1.199	-0.959	[0.5 - 2]
Total Score				4.74

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.16	1.000	-0.623	0	[1 - 100]
returnOnEquityTTM	0.618	2.50	6.30	6.36	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.30	2.00	9.23	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.09	2.00	8.97	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.143	1.500	-4.29	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.125	1.000	9.37	0	[0.1 - 0.5]
Total Score				3.23

BAUSCH HEALTH COMPANIES

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Echtzeitaktualisierungen für BAUSCH HEALTH COMPANIES [BHC.TO]

Upcoming Earnings Alert

BAUSCH HEALTH COMPANIES Dividend Information - Ex Dividend Junior

Dividend Commentary

Top 10 dividend Companies for TSX

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)